| Title : Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence - Dahl_2006_Pharmacogenomics.J_6_194 |
| Author(s) : Dahl JP , Jepson C , Levenson R , Wileyto EP , Patterson F , Berrettini WH , Lerman C |
| Ref : Pharmacogenomics J , 6 :194 , 2006 |
| Abstract : |
| PubMedSearch : Dahl_2006_Pharmacogenomics.J_6_194 |
| PubMedID: 16402081 |
| Title : Association of OPRM1 A118G variant with the relative reinforcing value of nicotine - Ray_2006_Psychopharmacology.(Berl)_188_355 |
| Author(s) : Ray R , Jepson C , Patterson F , Strasser A , Rukstalis M , Perkins K , Lynch KG , O'Malley S , Berrettini WH , Lerman C |
| Ref : Psychopharmacology (Berl) , 188 :355 , 2006 |
| Abstract : |
| PubMedSearch : Ray_2006_Psychopharmacology.(Berl)_188_355 |
| PubMedID: 16960700 |
| Title : Pharmacogenetics and nicotine addiction treatment - Munafo_2005_Pharmacogenomics_6_211 |
| Author(s) : Munafo MR , Shields AE , Berrettini WH , Patterson F , Lerman C |
| Ref : Pharmacogenomics , 6 :211 , 2005 |
| Abstract : |
| PubMedSearch : Munafo_2005_Pharmacogenomics_6_211 |
| PubMedID: 16013953 |
| Title : The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial - Lerman_2004_Pharmacogenomics.J_4_184 |
| Author(s) : Lerman C , Wileyto EP , Patterson F , Rukstalis M , Audrain-McGovern J , Restine S , Shields PG , Kaufmann V , Redden D , Benowitz N , Berrettini WH |
| Ref : Pharmacogenomics J , 4 :184 , 2004 |
| Abstract : |
| PubMedSearch : Lerman_2004_Pharmacogenomics.J_4_184 |
| PubMedID: 15007373 |